Finnegan Ip Law Podcast Series

Biotechnology and pharmaceutical companies are awaiting the FDA’s new regulations for implementing the 2010 Biologics Price Competition and Innovation Act (BPCIA), which will aim to provide an expedited approval framework for follow-on biologics.  While industry leaders can only speculate on the content of those regulations, Finnegan partner Bill Lewris compares the key differences between the BPCIA and Hatch-Waxman Act, including what type of follow-on biologics the BPCIA contemplates, exclusivity periods, and the patent litigation process.

To the average airline passenger, it seems as though aviation technology has been slow to evolve. In fact, there hasn’t been a radical change in commercial aviation design since the first flight of the de Havilland Comet in 1949. However, aviation manufacturing leaders like Boeing have been making significant strides in the market, recently announcing patented technology aimed at increasing fuel efficiency, reducing cabin noise, and maximizing passenger comfort.  In this podcast, Finnegan partner Lionel Lavenue explains the importance of Boeing’s new patents, what they mean for the future of aviation, and how our flight experience may be drastically different in the not-so-distant future.

Beyond the white lines, professional and collegiate sporting teams, athletes and apparel lines face fierce trademark challenges posed by rival teams, counterfeiters, and infringers. Finnegan partner Doug Rettew leads a discussion regarding the ins and outs of trademark protection in the sport industry.

Intellectual property has fueled the fire of innovation in China.  Over the past twenty-five years, China has transformed itself from a predominately agricultural society to a manufacturing powerhouse.  In this podcast Finnegan partner Esther Lim discusses China's current IP landscape and best practices and strategies for domestic and foreign companies doing business in China.

On the last day of its term on June 28, 2010, the U.S. Supreme Court handed down its long-awaited ruling in Bilski v. Kappos. From that moment, everyone from business executives to scientists have been trying to piece together the court’s opinion and understand what it could mean for their intellectual property protection. Finnegan partner Erika Arner, discusses the ruling and explains what inventors, scientists, and business owners need to know moving forward.

In January, the Federal Circuit upheld a District Court decision in Wyeth v. Kappos regarding the proper calculation of a patent term adjustment for issued patents. As a result, the U.S. Patent and Trademark Office has agreed to comply with the decision when calculating patent term adjustments for patents issued after March 2, 2010. Finnegan partner, Leslie McDonell, discusses the Wyeth v. Kappos case, the effect on patent term adjustments, and how this decision will change a company's patent filing strategy.

Finnegan partners Dori Hines and Darren Jiron discuss important cases in the Electrical and Computer Technology industry for 2010, the impact of the decisions in those cases, and potential outcomes.

In part two of the alternative energy podcast series, Finnegan partner Eric Raciti explains how clean tech companies can protect their IP.

In part one of the alternative energy podcast series, Finnegan partner Eric Raciti explains how clean tech companies can protect their IP.

Finnegan partner Mike Jakes analyzes the Federal Circuit's decision in the Bilski case, and discusses why the Supreme court should hear the case.

Finnegan partner Robert Yoches takes a closer look at the Federal Circuit's reversal of the District Court's decision in Muniauction, Inc. v. Thomson Corporation and I-Deal, LLC.

Finnegan attorneys Christine Lehman and Ronald Smith discuss the issues veterans face with disability claims.

Finnegan partner Erika Arner examines recent patent case law and asks if the time has come for the Supreme Court to redefine what kinds of inventions may be patented.